Global Meningococcal Vaccines Market Analysis To Reach US$ 6.05Bn By 203 and Japan Updates | Japan News

Meningococcal Vaccine Market Size reached US$ 3.47 Billion in 2024 and is expected to reach US$ 6.05 Billion by 2033, growing at a CAGR of 6.4% during the forecast period 2025-2033.

Recent News Study in Japan:

MenACWY conjugate vaccines have been available since May 2015 in Japan, but they remain classified as voluntary and are not part of the routine national immunization schedule

Unlock exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://datamintelligence.com/download-sample/meningococcal-vaccines-market?kb

Meningococcal Vaccines Market Overview

The Meningococcal Vaccines encompasses manufacturers and stakeholders involved in developing, licensing, distributing, and selling vaccines that protect against invasive Neisseria meningitidis infections. These vaccines polysaccharide, conjugate, and recombinant types target major serogroups (A, B, C, W, Y) and aim to reduce global public-health burden

Research Methodology:

The global Meningococcal Vaccines Market research report is based on a combination of primary and secondary data sources. The study carefully analyzes various factors influencing the industry, including government regulations, market dynamics, competitive landscape, historical trends, current conditions, and technological progress. It also evaluates future developments, related industry trends, market volatility, growth prospects, potential obstacles, and emerging challenges.

Segment Covered in the Meningococcal Vaccines Market:

By Type: Monovalent, Quadrivalent, Bivalent, Others

By Product Type: Polysaccharide Meningococcal Vaccines, Conjugate Meningococcal Vaccines, Serogroup Meningococcal Vaccines

By End-User: Hospitals, Specialty Clinics, Public Health Agencies, Other

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/meningococcal-vaccines-market?kb

List of the Key Players in the Meningococcal Vaccines Market:

Sanofi S.A., GlaxoSmithKline Inc., Merck & Co., Inc., Pfizer Inc., Bio-Med (P) Limited, Serum Institute of India Pvt. Ltd., Walvax Biotechnology Co., Ltd., and Incepta Pharmaceuticals Ltd., among others.

Industry Development:

In February 2025, GSK plc announced that the U.S. Food and Drug Administration (FDA) approved Penmenvy, a vaccine targeting meningococcal groups A, B, C, W, and Y, for use in individuals aged 10 to 25 years. This vaccine addresses the five major serogroups responsible for invasive meningococcal disease (IMD). Penmenvy integrates antigenic components from GSK's existing vaccines-Bexsero (targeting group B) and Menveo (covering groups A, C, Y, and W-135).

In June 2024, Gavi, the Vaccine Alliance, announced that low-income countries supported by the alliance are now eligible to apply for the introduction of four additional vaccines, including a multivalent meningococcal conjugate vaccine. These vaccine programs had been previously approved by the Gavi Board.

Regional Analysis for Meningococcal Vaccines Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Go-to-market Strategy.

➡ Neutral perspective on the market performance.

➡ Customized regional/country reports as per request and country level analysis.

➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➠ What are the global sales, production, consumption, imports, and exports in the Meningococcal Vaccines market?

➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?

➠ What key opportunities and challenges do vendors face in the Meningococcal Vaccines industry?

➠ Which product types, applications, or end-users are driving market growth, and what is their market share?

➠ What are the major growth drivers and restraints of the Meningococcal Vaccines market?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?kb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.